Sichuan Hebang Biotechnology Co Ltd
Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging … Read more
Market Cap & Net Worth: Sichuan Hebang Biotechnology Co Ltd (603077)
Sichuan Hebang Biotechnology Co Ltd (SHG:603077) has a market capitalization of $3.95 Billion (CN¥28.97 Billion) as of March 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #4631 globally and #509 in its home market, demonstrating a 17.56% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sichuan Hebang Biotechnology Co Ltd's stock price CN¥3.28 by its total outstanding shares 8831529228 (8.83 Billion).
Sichuan Hebang Biotechnology Co Ltd Market Cap History: 2015 to 2026
Sichuan Hebang Biotechnology Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $3.53 Billion to $3.95 Billion (1.80% CAGR).
Sichuan Hebang Biotechnology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sichuan Hebang Biotechnology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.29x
Sichuan Hebang Biotechnology Co Ltd's market cap is 0.29 times its annual revenue
8.83x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
78.04x
Sichuan Hebang Biotechnology Co Ltd's market cap is 78.04 times its annual earnings
4.17x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.53 Billion | $2.86 Billion | $239.87 Million | 1.23x | 14.74x |
| 2016 | $2.69 Billion | $3.46 Billion | $317.81 Million | 0.78x | 8.48x |
| 2017 | $2.33 Billion | $4.74 Billion | $517.54 Million | 0.49x | 4.49x |
| 2018 | $1.91 Billion | $6.01 Billion | $363.09 Million | 0.32x | 5.25x |
| 2019 | $1.74 Billion | $5.97 Billion | $516.85 Million | 0.29x | 3.37x |
| 2020 | $1.67 Billion | $5.26 Billion | $40.94 Million | 0.32x | 40.80x |
| 2021 | $4.01 Billion | $9.99 Billion | $3.02 Billion | 0.40x | 1.33x |
| 2022 | $3.59 Billion | $13.04 Billion | $3.81 Billion | 0.28x | 0.94x |
| 2023 | $2.84 Billion | $8.82 Billion | $1.28 Billion | 0.32x | 2.21x |
| 2024 | $2.46 Billion | $8.55 Billion | $31.46 Million | 0.29x | 78.04x |
Competitor Companies of 603077 by Market Capitalization
Companies near Sichuan Hebang Biotechnology Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Sichuan Hebang Biotechnology Co Ltd by market ranking:
- Linde PLC (XETRA:LIN): Ranked #84 globally with a market cap of $187.60 Billion USD ( €182.76 Billion EUR).
- BASF SE NA O.N. (OTCQX:BFFAF): Ranked #459 globally with a market cap of $47.09 Billion USD.
- Shin-Etsu Chemical Co. Ltd (PINK:SHECF): Ranked #467 globally with a market cap of $46.17 Billion USD.
- A. Schulman Inc (PINK:SLMNP): Ranked #824 globally with a market cap of $23.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Linde PLC | XETRA:LIN | $187.60 Billion | €430.60 |
| #459 | BASF SE NA O.N. | OTCQX:BFFAF | $47.09 Billion | $53.46 |
| #467 | Shin-Etsu Chemical Co. Ltd | PINK:SHECF | $46.17 Billion | $24.66 |
| #824 | A. Schulman Inc | PINK:SLMNP | $23.93 Billion | $901.00 |
Sichuan Hebang Biotechnology Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Sichuan Hebang Biotechnology Co Ltd's market cap moved from $3.53 Billion to $ 3.95 Billion, with a yearly change of 1.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥3.95 Billion | +45.13% |
| 2025 | CN¥2.72 Billion | +10.78% |
| 2024 | CN¥2.46 Billion | -13.56% |
| 2023 | CN¥2.84 Billion | -20.94% |
| 2022 | CN¥3.59 Billion | -10.42% |
| 2021 | CN¥4.01 Billion | +140.14% |
| 2020 | CN¥1.67 Billion | -4.05% |
| 2019 | CN¥1.74 Billion | -8.64% |
| 2018 | CN¥1.91 Billion | -18.07% |
| 2017 | CN¥2.33 Billion | -13.69% |
| 2016 | CN¥2.69 Billion | -23.77% |
| 2015 | CN¥3.53 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Sichuan Hebang Biotechnology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.95 Billion USD |
| MoneyControl | $3.95 Billion USD |
| MarketWatch | $3.95 Billion USD |
| marketcap.company | $3.95 Billion USD |
| Reuters | $3.95 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.